597 related articles for article (PubMed ID: 17537625)
1. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; Remon JP; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
[TBL] [Abstract][Full Text] [Related]
2. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
3. Development of starch-based pellets via extrusion/spheronisation.
Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of modified starches in direct compression of a poorly water soluble drug (hydrochlorothiazide).
Okafor IS; Ofoefule SI; Udeala OK
Boll Chim Farm; 2001; 140(1):36-9. PubMed ID: 11338775
[TBL] [Abstract][Full Text] [Related]
5. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
6. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
Chatchawalsaisin J; Podczeck F; Newton JM
Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
[TBL] [Abstract][Full Text] [Related]
7. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
Mehta S; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
[TBL] [Abstract][Full Text] [Related]
8. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.
Iosio T; Voinovich D; Grassi M; Pinto JF; Perissutti B; Zacchigna M; Quintavalle U; Serdoz F
Eur J Pharm Biopharm; 2008 Jun; 69(2):686-97. PubMed ID: 18191390
[TBL] [Abstract][Full Text] [Related]
9. Preparation of starch-based pellets by hot-melt extrusion.
Bialleck S; Rein H
Eur J Pharm Biopharm; 2011 Oct; 79(2):440-8. PubMed ID: 21570466
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator.
Pai R; Kohli K; Jain G; Srivastava B
Arch Pharm Res; 2011 Jul; 34(7):1135-42. PubMed ID: 21811920
[TBL] [Abstract][Full Text] [Related]
11. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
[TBL] [Abstract][Full Text] [Related]
12. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
13. Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique.
Cao QR; Liu Y; Xu WJ; Lee BJ; Yang M; Cui JH
Int J Pharm; 2012 Sep; 434(1-2):325-33. PubMed ID: 22688251
[TBL] [Abstract][Full Text] [Related]
14. Starch-dextrin mixtures as base excipients for extrusion-spheronization pellets.
Almeida Prieto S; Blanco Méndez J; Otero Espinar FJ
Eur J Pharm Biopharm; 2005 Apr; 59(3):511-21. PubMed ID: 15760732
[TBL] [Abstract][Full Text] [Related]
15. Dissolution rate enhancement of piroxicam by ordered mixing.
Saharan VA; Choudhury PK
Pak J Pharm Sci; 2012 Jul; 25(3):521-33. PubMed ID: 22713937
[TBL] [Abstract][Full Text] [Related]
16. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
[TBL] [Abstract][Full Text] [Related]
17. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.
Zhang Y; Wang R; Wu J; Shen Q
Int J Pharm; 2012 May; 427(2):337-44. PubMed ID: 22366381
[TBL] [Abstract][Full Text] [Related]
18. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
Thommes M; Kleinebudde P
AAPS PharmSciTech; 2007 Nov; 8(4):E95. PubMed ID: 18181555
[TBL] [Abstract][Full Text] [Related]
19. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets.
Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
Int J Pharm; 2010 Mar; 388(1-2):64-72. PubMed ID: 20035851
[TBL] [Abstract][Full Text] [Related]
20. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Eur J Pharm Biopharm; 2011 Nov; 79(3):658-63. PubMed ID: 21827853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
